A retrospective study of humoral response to mRNA vaccines or inactivated virus vaccines in patients with neuromyelitis optica spectrum disorder (NMOSD) or MOG Antibody Disease (MOGAD)
Latest Information Update: 13 Dec 2021
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 13 Dec 2021 New trial record
- 15 Oct 2021 Results presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis